137396-01-1

Basic information

• Product Name: 4-BROMO-3-METHOXYPHENYL PARATOSYLATE
• Synonyms: 4-BROMO-3-METHOXYPHENYL PARATOSYLATE;4-Bromo-3-methoxyphenyl 4-methylbenzenesulfonate
• CAS NO: 137396-01-1
• Molecular Formula: C₁₄H₁₃BrO₄S
• Molecular Weight: 357.22
• Mol File: 137396-01-1.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 462.7°Cat760mmHg
• Flash Point: 233.6°C
• Appearance: /
• Density: 1.491g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.589
• CAS DataBase Reference: 4-BROMO-3-METHOXYPHENYL PARATOSYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BROMO-3-METHOXYPHENYL PARATOSYLATE(137396-01-1)
• EPA Substance Registry System: 4-BROMO-3-METHOXYPHENYL PARATOSYLATE(137396-01-1)

Safety Data

• Hazardous Substances Data: 137396-01-1(Hazardous Substances Data)

Usage

InChI:InChI=1/C14H13BrO4S/c1-10-3-6-12(7-4-10)20(16,17)19-11-5-8-13(15)14(9-11)18-2/h3-9H,1-2H3

Upstream product

• 98-59-9 p-toluenesulfonyl chloride 
• 6626-15-9 4-Bromoresorcinol 
• 74-88-4 methyl iodide 
• 494773-45-4 4-bromo-3-hydroxy-phenyl 4-methyl-benzenesulfonate 

Downstream Products

• 1320343-74-5 C₂₄H₂₂FN₃OS 
• 1320343-88-1 C₂₄H₂₁FN₄O 
• 1320343-89-2 C₂₅H₂₄FN₃OS 
• 1320343-90-5 C₂₆H₂₄FN₃O 
• 1320343-71-2 C₁₄H₁₅BO₆S 
• 1320343-72-3 C₁₈H₁₇NO₄S₂ 
• 1320343-73-4 C₁₇H₂₂BNO₃S 
• 1346754-00-4 C₁₁H₁₁NO₂S 
• 1346753-99-8 C₁₂H₁₀F₃NO₄S₂ 

Relevant articles and documents

ANTI-FUNGAL TREATMENT

Provided are compounds, methods, and pharmaceutical compositions useful for treatment of fungal infections, e.g., aspergillosis, candidiasis, cryptococcosis, histoplasmosis, and the like. For example, the pharmaceutical composition may include a pharmaceutically acceptable carrier or excipient, and a compound represented by Ar— C(=NR1)NR2— A---X— Y— Het2 and pharmaceutically acceptable salts thereof. Ar may be an optionally substituted aryl or nitrogen- containing heteroaryl. R1 and R2 may independently be H, optionally substituted C1-C6 aikyi, or optionally substituted C3-C6 cyeloalkyi. A may be a bond or an optionally substituted linking moiety comprising 1, 2, or 3 rings. Each ring in the optionally substituted linking moiety may independently be one of: aryl, cyeloalkyi, heterocycloalkyl, and heteroaryl. X may be O, S, amide, or a bond. Y may be optionally substituted C1-C10 alkyi or optionally substituted C2-C10 alkenyl. Het2 may be an optionally substituted five-membered nitrogen-containing heteroaromatic ring comprising 1, 2, or 3 ring heteroatoms.

A highly diastereoselective oxa-Pictet-Spengler approach to (+)-astropaquinone B and (+)-astropaquinone C and the formation of astropaquinone B dimer

A concise and highly diastereoselective synthesis of (+)-astropaquinone B and (+)-astropaquinone C is reported. The synthetic strategy is based on an efficient combination of Doetz benzannulation using a chiral alkyne to construct the naphthalene unit and

An enzymatically activated fluorescence probe for targeted tumor imaging

β-Galactosidase is a widely used reporter enzyme, but although several substrates are available for in vitro detection, its application for in vivo optical imaging remains a challenge. To obtain a probe suitable for in vivo use, we modified our previously